Showing results (211-220 of 266) with videos related to

Sort By:
Pageof 27
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2025
Comparison of visual and analytic methods of Alzheimer's disease pathologic stagingBrian J Lopresti, Ann D Cohen, Alex DelBene, et al.
Annals of Clinical and Translational Neurology|August 1, 2020
Hippocampal sclerosis, TDP-43, and the duration of the symptoms of dementia of AD patientsOscar L Lopez, Julia Kofler, YueFang Chang, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2004
Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndromeJ J Y Sung, W K Leung, J Y L Ching, et al.
Neurobiology of Disease|July 26, 2016
Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP(+) exposureApril A Dukes, Qing Bai, Victor S Van Laar, et al.
Neurology|September 13, 2024
Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer DiseaseHye Joo Son, Jae Seung Kim, Randall J Bateman, et al.
Controlled Clinical Trials|March 11, 1998
Stroke prevention trial in sickle cell anemiaR J Adams, V C McKie, D Brambilla, et al.
Molecular Neurodegeneration|May 15, 2024
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reportingXuemei Zeng, Yijun Chen, Anuradha Sehrawat, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progressionXuemei Zeng, Marissa F Farinas, Michel N Nafash, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies ConsortiumLavanya Jain, Maria Khrestian, Shane Formica, et al.
Pageof 27